159 related articles for article (PubMed ID: 28795143)
1. High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients.
Goodall DL; Willicombe M; McLean AG; Taube D
Transplant Direct; 2017 Aug; 3(8):e192. PubMed ID: 28795143
[TBL] [Abstract][Full Text] [Related]
2. Patterns in Tacrolimus Variability and Association with
Piburn KH; Sigurjonsdottir VK; Indridason OS; Maestretti L; Patton MV; McGrath A; Palsson R; Gallo A; Chaudhuri A; Grimm PC
Clin J Am Soc Nephrol; 2022 Aug; 17(8):1194-1203. PubMed ID: 35882506
[TBL] [Abstract][Full Text] [Related]
3. Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes.
González-Vílchez F; Crespo-Leiro MG; Delgado-Jiménez J; Pérez-Villa F; Segovia-Cubero J; Díaz-Molina B; Mirabet-Pérez S; Arizón Del Prado JM; Blasco-Peiró T; Martínez-Sellés M; Almenar-Bonet L; Garrido-Bravo I; Rábago G; Vázquez de Prada JA
Rev Esp Cardiol (Engl Ed); 2022 Feb; 75(2):129-140. PubMed ID: 33744197
[TBL] [Abstract][Full Text] [Related]
4. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation.
Shuker N; Shuker L; van Rosmalen J; Roodnat JI; Borra LC; Weimar W; Hesselink DA; van Gelder T
Transpl Int; 2016 Nov; 29(11):1158-1167. PubMed ID: 27188932
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective.
Schumacher L; Leino AD; Park JM
Pharmacotherapy; 2021 Jan; 41(1):103-118. PubMed ID: 33131078
[TBL] [Abstract][Full Text] [Related]
6. Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant.
Shuker N; Bouamar R; Hesselink DA; van Gelder T; Caliskan K; Manintveld OC; Balk AH; Constantinescu AA
Exp Clin Transplant; 2018 Jun; 16(3):326-332. PubMed ID: 28969528
[TBL] [Abstract][Full Text] [Related]
7. Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial.
Fleming JN; Gebregziabher M; Posadas A; Su Z; McGillicuddy JW; Taber DJ
Am J Health Syst Pharm; 2021 Jul; 78(14):1287-1293. PubMed ID: 33821958
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence.
Herblum J; Dacouris N; Huang M; Zaltzman J; Prasad GVR; Nash M; Chen L
Can J Kidney Health Dis; 2021; 8():20543581211021742. PubMed ID: 34188946
[TBL] [Abstract][Full Text] [Related]
9. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development.
Rodrigo E; Segundo DS; Fernández-Fresnedo G; López-Hoyos M; Benito A; Ruiz JC; de Cos MA; Arias M
Transplantation; 2016 Nov; 100(11):2479-2485. PubMed ID: 26703349
[TBL] [Abstract][Full Text] [Related]
10. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation.
van der Veer MAA; Nangrahary N; Hesselink DA; Erler NS; Metselaar HJ; van Gelder T; Darwish Murad S
Transplantation; 2019 Nov; 103(11):2329-2337. PubMed ID: 30801539
[TBL] [Abstract][Full Text] [Related]
11. High tacrolimus intra-patient variability is associated with graft rejection, and
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.
Pizzo HP; Ettenger RB; Gjertson DW; Reed EF; Zhang J; Gritsch HA; Tsai EW
Pediatr Nephrol; 2016 Dec; 31(12):2345-2352. PubMed ID: 27286686
[TBL] [Abstract][Full Text] [Related]
13. Influence of Tacrolimus Intrapatient Variability on Allograft Rejection Frequency and Survival Following Liver Transplantation.
Soares ME; Costa G; Guerra L; Morais MC; Vaz N; Codes L; Bittencourt PL
Ther Drug Monit; 2024 Mar; ():. PubMed ID: 38648652
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant.
Hage V; Ferrandiz I; Béllière J; Esposito L; Hebral AL; Cointault O; Del Bello A; Kamar N
Exp Clin Transplant; 2019 Jun; 17(3):313-319. PubMed ID: 30602364
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
Sablik KA; Clahsen-van Groningen MC; Hesselink DA; van Gelder T; Betjes MGH
PLoS One; 2018; 13(5):e0196552. PubMed ID: 29746495
[TBL] [Abstract][Full Text] [Related]
16. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal.
Pierce DR; West-Thielke P; Hajjiri Z; Gaitonde S; Tzvetanov I; Benedetti E; Lichvar AB
Transplant Direct; 2021 Jun; 7(6):e698. PubMed ID: 34036168
[TBL] [Abstract][Full Text] [Related]
18. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.
Abu Bakar K; Mohamad NA; Hodi Z; McCulloch T; Williams A; Christian M; Key T; Kim JJ
Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127
[TBL] [Abstract][Full Text] [Related]
19. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
Jung HY; Seo MY; Jeon Y; Huh KH; Park JB; Jung CW; Lee S; Han SY; Ro H; Yang J; Ahn C; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
PLoS One; 2020; 15(7):e0235418. PubMed ID: 32614859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
